Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation

Rachel B. Salit, Daniel H. Fowler, Robert M. Dean, Steven Z. Pavletic, Frances T. Hakim, Seth M. Steinberg, Nancy T. Hardy, Claude Sportes, Ronald E. Gress, Michael R. Bishop

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (RIC-alloHSCT) is associated with lower toxicity but higher rates of prolonged mixed chimerism than myeloablative conditioning. Decreased pretransplantation host T cell numbers are associated with less graft rejection and early full donor chimerism. To compensate for variability in pretransplantation host lymphocyte numbers and facilitate the achievement of rapid full donor chimerism, we tested a strategy of targeted lymphocyte depletion (TLD) using chemotherapy at conventional doses to provide cytoreduction and lymphocyte depletion before RIC-alloHSCT. In our study, 111 patients with advanced hematologic malignancies received 1 to 3 cycles of conventional-dose chemotherapy to reduce circulating lymphocytes to a predetermined level. Patients then underwent RIC-alloHSCT from HLA-matched siblings. Patients received a median of 2 cycles of TLD chemotherapy, resulting in a median 71% decline in CD4+ count. All patients engrafted; there were no late graft failures. By day+14, median CD3+ chimerism was 99% donor and was significantly associated with lower post-TLD CD4+ counts (P=012). One- and 5-year treatment-related mortality were 15% and 21%, respectively. At 1-year follow-up, 66% of patients had achieved complete remission (CR) of which 92% were not in CR at the time of transplantation. Overall survival at 1 and 5years post transplantation were 66% and 47%, respectively.

Original languageEnglish (US)
Pages (from-to)1509-1513
Number of pages5
JournalBiology of Blood and Marrow Transplantation
Volume19
Issue number10
DOIs
StatePublished - Oct 1 2013
Externally publishedYes

Fingerprint

Lymphocyte Depletion
Chimerism
Stem Cell Transplantation
Tissue Donors
CD4 Lymphocyte Count
Drug Therapy
Transplantation
Hematopoietic Stem Cell Transplantation
Lymphocyte Count
Graft Rejection
Hematologic Neoplasms
Siblings
Cell Count
Lymphocytes
T-Lymphocytes
Transplants
Survival
Mortality
Conditioning (Psychology)

Keywords

  • Engraftment
  • Lymphocyte depletion
  • Reduced-intensity transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation. / Salit, Rachel B.; Fowler, Daniel H.; Dean, Robert M.; Pavletic, Steven Z.; Hakim, Frances T.; Steinberg, Seth M.; Hardy, Nancy T.; Sportes, Claude; Gress, Ronald E.; Bishop, Michael R.

In: Biology of Blood and Marrow Transplantation, Vol. 19, No. 10, 01.10.2013, p. 1509-1513.

Research output: Contribution to journalArticle

Salit, RB, Fowler, DH, Dean, RM, Pavletic, SZ, Hakim, FT, Steinberg, SM, Hardy, NT, Sportes, C, Gress, RE & Bishop, MR 2013, 'Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation', Biology of Blood and Marrow Transplantation, vol. 19, no. 10, pp. 1509-1513. https://doi.org/10.1016/j.bbmt.2013.08.001
Salit, Rachel B. ; Fowler, Daniel H. ; Dean, Robert M. ; Pavletic, Steven Z. ; Hakim, Frances T. ; Steinberg, Seth M. ; Hardy, Nancy T. ; Sportes, Claude ; Gress, Ronald E. ; Bishop, Michael R. / Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation. In: Biology of Blood and Marrow Transplantation. 2013 ; Vol. 19, No. 10. pp. 1509-1513.
@article{3656c9d7cf88415c9075de8d5d43ae10,
title = "Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation",
abstract = "Reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (RIC-alloHSCT) is associated with lower toxicity but higher rates of prolonged mixed chimerism than myeloablative conditioning. Decreased pretransplantation host T cell numbers are associated with less graft rejection and early full donor chimerism. To compensate for variability in pretransplantation host lymphocyte numbers and facilitate the achievement of rapid full donor chimerism, we tested a strategy of targeted lymphocyte depletion (TLD) using chemotherapy at conventional doses to provide cytoreduction and lymphocyte depletion before RIC-alloHSCT. In our study, 111 patients with advanced hematologic malignancies received 1 to 3 cycles of conventional-dose chemotherapy to reduce circulating lymphocytes to a predetermined level. Patients then underwent RIC-alloHSCT from HLA-matched siblings. Patients received a median of 2 cycles of TLD chemotherapy, resulting in a median 71{\%} decline in CD4+ count. All patients engrafted; there were no late graft failures. By day+14, median CD3+ chimerism was 99{\%} donor and was significantly associated with lower post-TLD CD4+ counts (P=012). One- and 5-year treatment-related mortality were 15{\%} and 21{\%}, respectively. At 1-year follow-up, 66{\%} of patients had achieved complete remission (CR) of which 92{\%} were not in CR at the time of transplantation. Overall survival at 1 and 5years post transplantation were 66{\%} and 47{\%}, respectively.",
keywords = "Engraftment, Lymphocyte depletion, Reduced-intensity transplantation",
author = "Salit, {Rachel B.} and Fowler, {Daniel H.} and Dean, {Robert M.} and Pavletic, {Steven Z.} and Hakim, {Frances T.} and Steinberg, {Seth M.} and Hardy, {Nancy T.} and Claude Sportes and Gress, {Ronald E.} and Bishop, {Michael R.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.bbmt.2013.08.001",
language = "English (US)",
volume = "19",
pages = "1509--1513",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation

AU - Salit, Rachel B.

AU - Fowler, Daniel H.

AU - Dean, Robert M.

AU - Pavletic, Steven Z.

AU - Hakim, Frances T.

AU - Steinberg, Seth M.

AU - Hardy, Nancy T.

AU - Sportes, Claude

AU - Gress, Ronald E.

AU - Bishop, Michael R.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (RIC-alloHSCT) is associated with lower toxicity but higher rates of prolonged mixed chimerism than myeloablative conditioning. Decreased pretransplantation host T cell numbers are associated with less graft rejection and early full donor chimerism. To compensate for variability in pretransplantation host lymphocyte numbers and facilitate the achievement of rapid full donor chimerism, we tested a strategy of targeted lymphocyte depletion (TLD) using chemotherapy at conventional doses to provide cytoreduction and lymphocyte depletion before RIC-alloHSCT. In our study, 111 patients with advanced hematologic malignancies received 1 to 3 cycles of conventional-dose chemotherapy to reduce circulating lymphocytes to a predetermined level. Patients then underwent RIC-alloHSCT from HLA-matched siblings. Patients received a median of 2 cycles of TLD chemotherapy, resulting in a median 71% decline in CD4+ count. All patients engrafted; there were no late graft failures. By day+14, median CD3+ chimerism was 99% donor and was significantly associated with lower post-TLD CD4+ counts (P=012). One- and 5-year treatment-related mortality were 15% and 21%, respectively. At 1-year follow-up, 66% of patients had achieved complete remission (CR) of which 92% were not in CR at the time of transplantation. Overall survival at 1 and 5years post transplantation were 66% and 47%, respectively.

AB - Reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (RIC-alloHSCT) is associated with lower toxicity but higher rates of prolonged mixed chimerism than myeloablative conditioning. Decreased pretransplantation host T cell numbers are associated with less graft rejection and early full donor chimerism. To compensate for variability in pretransplantation host lymphocyte numbers and facilitate the achievement of rapid full donor chimerism, we tested a strategy of targeted lymphocyte depletion (TLD) using chemotherapy at conventional doses to provide cytoreduction and lymphocyte depletion before RIC-alloHSCT. In our study, 111 patients with advanced hematologic malignancies received 1 to 3 cycles of conventional-dose chemotherapy to reduce circulating lymphocytes to a predetermined level. Patients then underwent RIC-alloHSCT from HLA-matched siblings. Patients received a median of 2 cycles of TLD chemotherapy, resulting in a median 71% decline in CD4+ count. All patients engrafted; there were no late graft failures. By day+14, median CD3+ chimerism was 99% donor and was significantly associated with lower post-TLD CD4+ counts (P=012). One- and 5-year treatment-related mortality were 15% and 21%, respectively. At 1-year follow-up, 66% of patients had achieved complete remission (CR) of which 92% were not in CR at the time of transplantation. Overall survival at 1 and 5years post transplantation were 66% and 47%, respectively.

KW - Engraftment

KW - Lymphocyte depletion

KW - Reduced-intensity transplantation

UR - http://www.scopus.com/inward/record.url?scp=84884201415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884201415&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2013.08.001

DO - 10.1016/j.bbmt.2013.08.001

M3 - Article

C2 - 23948062

AN - SCOPUS:84884201415

VL - 19

SP - 1509

EP - 1513

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 10

ER -